Core Viewpoint - The company announced that its wholly-owned subsidiary, Jiangsu Shenhua Pharmaceutical Co., Ltd., has received the acceptance notice for the registration application of Lactulose Oral Solution from the National Medical Products Administration, indicating the product has entered the registration review stage [1] Group 1: Product Details - Lactulose Oral Solution is a laxative characterized by its quick, gentle, and effective action, with high safety, making it suitable for individuals with chronic or habitual constipation [1] Group 2: Regulatory Process - The acceptance of the drug registration application signifies that the product is now in the registration review phase, with completion time, approval results, and post-approval sales conditions remaining uncertain [1] Group 3: Financial Impact - The company stated that the registration application will not have a significant impact on its short-term performance [1]
华人健康：全资子公司收到乳果糖口服溶液药品注册受理通知书